Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 40
SponsorZhujiang Hospital
About this trial
The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.
Eligibility criteria
Qualifiers
healthy pregnant women aged between 20y and 40y.
Vaginal birth
BMI<23.5 before pregnancy
Infants' birth weight, between 2500g and 4000g.
Disqualifiers
gestational diabetes
diagnosis of depressive disorder during pregnancy
gestational hypertension
diagnosis of other diseases during pregnancy
Trial design
Treatments tested in this trial
- Sample collection
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov